Grosios K - Search Results

1

Genomic structures of the human angiopoietins show polymorphism in angiopoietin-2.

Ward EG, Grosios K, Markham AF, Jones PF. Ward EG, et al. Among authors: grosios k. Cytogenet Cell Genet. 2001;94(3-4):147-54. doi: 10.1159/000048807. Cytogenet Cell Genet. 2001. PMID: 11856872

2

Assignment of ANGPT4, ANGPT1, and ANGPT2 encoding angiopoietins 4, 1 and 2 to human chromosome bands 20p13, 8q22.3-->q23 and 8p23.1, respectively, by in situ hybridization and radiation hybrid mapping.

Grosios K, Leek JP, Markham AF, Yancopoulos GD, Jones PF. Grosios K, et al. Cytogenet Cell Genet. 1999;84(1-2):118-20. doi: 10.1159/000015235. Cytogenet Cell Genet. 1999. PMID: 10343124 No abstract available.

3

Endostatin (EntreMed).

Grosios K. Grosios K. IDrugs. 2000 Jul;3(7):799-810. IDrugs. 2000. PMID: 16080055

4

UCN-01 Kyowa Hakko Kogyo Co.

Grosios K. Grosios K. Curr Opin Investig Drugs. 2001 Feb;2(2):287-97. Curr Opin Investig Drugs. 2001. PMID: 11816846 Review.

5

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.

Grosios K, Holwell SE, McGown AT, Pettit GR, Bibby MC. Grosios K, et al. Br J Cancer. 1999 Dec;81(8):1318-27. doi: 10.1038/sj.bjc.6692174. Br J Cancer. 1999. PMID: 10604728 Free PMC article.

6

Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.

Holwell SE, Cooper PA, Grosios K, Lippert JW 3rd, Pettit GR, Shnyder SD, Bibby MC. Holwell SE, et al. Among authors: grosios k. Anticancer Res. 2002 Mar-Apr;22(2A):707-11. Anticancer Res. 2002. PMID: 12017147

7

MitoExtra SuperGen.

Grosios K. Grosios K. Curr Opin Investig Drugs. 2002 Apr;3(4):648-51. Curr Opin Investig Drugs. 2002. PMID: 12090738

8

Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma.

Grosios K, Loadman PM, Swaine DJ, Pettit GR, Bibby MC. Grosios K, et al. Anticancer Res. 2000 Jan-Feb;20(1A):229-33. Anticancer Res. 2000. PMID: 10769660

9

AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G. Traxler P, et al. Among authors: grosios k. Cancer Res. 2004 Jul 15;64(14):4931-41. doi: 10.1158/0008-5472.CAN-03-3681. Cancer Res. 2004. PMID: 15256466

10

The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.

Akeno-Stuart N, Croyle M, Knauf JA, Malaguarnera R, Vitagliano D, Santoro M, Stephan C, Grosios K, Wartmann M, Cozens R, Caravatti G, Fabbro D, Lane HA, Fagin JA. Akeno-Stuart N, et al. Among authors: grosios k. Cancer Res. 2007 Jul 15;67(14):6956-64. doi: 10.1158/0008-5472.CAN-06-4605. Cancer Res. 2007. PMID: 17638907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page